NUTX
Nutex Health
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: NUTX
- PE Ratio
The PE ratio for Nutex Health stock stands at 14.54 as of Jul 2, 2026. This is based on the current EPS of $13.52 and the stock price of $196.53 per share. An increase of 54% has been seen in the P/E ratio compared to the average of 9.5 of the last 4 quarters.
NUTX PE ratio history
Over the last five years, the average PE ratio of Nutex Health has been 10.16. The current 14.54 PE ratio is 43% above the historical average. Over the past five years, NUTX's PE ratio was at its highest in the Jun 2022 quarter at 26.88, with a price of $483.75 and an EPS of $18. The Dec 2024 quarter recorded the bottom point at 3.1, with a price of $31.69 and an EPS of $10.23.
Nutex Health PE ratio by year
Maximum annual increase: 377.1% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 14.79 | 377.1% | $164.62 | $11.13 |
| 2024 | 3.1 | N/A | $31.69 | $10.23 |
| 2023 | N/A | N/A | $27 | -$10.39 |
| 2022 | N/A | N/A | $285 | -$100.36 |
| 2021 | N/A | N/A | N/A | $33 |
| 2020 | N/A | N/A | N/A | $27 |
Nutex Health PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 7.03 | -52.47% | $95.04 | $13.52 |
| Dec 2025 | 14.79 | 203.7% | $164.62 | $11.13 |
| Sep 2025 | 4.87 | -56.17% | $103.32 | $21.2 |
| Jun 2025 | 11.11 | 232.63% | $124.49 | $11.21 |
| Mar 2025 | 3.34 | 7.74% | $47.03 | $14.09 |
| Dec 2024 | 3.1 | N/A | $31.69 | $10.23 |
| Sep 2024 | N/A | N/A | $21.7 | -$9.03 |
| Jun 2024 | N/A | N/A | $5.95 | -$8.56 |
| Mar 2024 | N/A | N/A | $14.39 | -$9.28 |
| Dec 2023 | N/A | N/A | $27 | -$10.39 |
| Sep 2023 | N/A | N/A | $30.38 | -$6.6 |
| Jun 2023 | N/A | N/A | $63.24 | -$98.35 |
| Mar 2023 | N/A | N/A | $151.5 | -$102.06 |
| Dec 2022 | N/A | N/A | $285 | -$100.36 |
| Sep 2022 | N/A | N/A | $225 | -$88.5 |
NUTX Price vs fair value
NUTX average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of NUTX is greater than its 3-year historical average.
PE comparison
With a P/E of 14.54, NUTX is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 26.04, Nutex Health's P/E is 44% lower.
Frequently asked questions
What is Nutex Health's PE ratio?
The price to earnings ratio for NUTX stock is 14.54 as of Jul 2, 2026.
What is the 3-year average PE ratio for Nutex Health (NUTX)?
As an average over the last 3 years, NUTX stock has a PE ratio of 7.37.
What is the highest PE ratio for NUTX?
Over the last five years, the quarterly PE ratio reached a historic high of 26.88 in the Jun 2022 quarter.
How does the current PE ratio for NUTX compare to its historical average?
NUTX's current price to earnings ratio is 43% above its 5-year historical average.
How is NUTX's PE ratio calculated (Nutex Health PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 2, 2026), Nutex Health's stock price is $196.53. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $13.52. Therefore, Nutex Health's P/E ratio for today is 14.54. PE RATIO(14.54) = STOCK PRICE($196.53) / TTM EPS($13.52)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.